Zhejiang Hisun Pharmaceutical (SHA:600267) plans to pay additional taxes and late fees amounting to 18.1 million yuan after an internal inspection, according to a Tuesday filing on the Shanghai Stock Exchange.
The amount included 15.5 million yuan in corporate income taxes, value-added taxes and other related taxes and 2.6 million yuan in late payment fees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments